The New England Journal of Medicine

Tighter blood pressure control cut cardiovascular events

Major cardiovascular events occurred in 10.9% of the intensive-treatment group versus 13.5% with standard treatment over a median 3.9 years.

Paper by Gisele Sampaio Silva, M. Julia Machline-Carrion, Karla Santo, +36 more authorsOtavio Berwanger · Hospital Israelita Albert Einstein · Imperial College London
Figure from The New England Journal of Medicine
Open the figure at full size
Sampaio Silva et al.
Studied:
Randomized trial in 4,368 people with previous ischemic stroke or TIA, median 3.9 years (Multicenter, registered NCT04036409)
What changed:
Major cardiovascular events were less common with intensive blood pressure treatment: 10.9% versus 13.5% with standard treatment
The catch:
Treatment awareness could influence hospitalization decisions counted as cardiovascular events
In the record:
The 57th paper on intensive blood pressure control with results in people; 75 on record in all.
Why it’s aging research:
It bears on staying healthy in midlife and later life.

Editor of record: Boris Djordjevic · AgingResearch.News

Follow @agingbrief

The 4,368 adults in a randomized trial at 30 Brazilian sites had elevated blood pressure and previous ischemic stroke, caused by blocked blood flow to the brain, or transient ischemic attack, a brief episode of stroke-like symptoms. Their average age was 63.9 years; 2,093 were women. Treatment targeted systolic pressure—the top blood pressure number—below 120 or 140 millimeters of mercury.

Over a median 3.9 years, the combined outcome occurred in 10.9% with intensive treatment and 13.5% with standard treatment. It included death from cardiovascular causes, nonfatal heart attack or stroke, or hospitalization for unstable angina, a type of heart-related chest pain, or heart failure. Intensive treatment more often led to a sustained decline of at least 50% in estimated kidney filtration or progression to kidney failure. Serious adverse events occurred at similar rates.

Why it matters

For people aging with a history of stroke or transient ischemic attack, choosing a blood pressure target involves weighing cardiovascular prevention against kidney health.

Caveats

Participants and clinicians knew the assigned treatment. The trial studied people with elevated blood pressure and a previous ischemic stroke or transient ischemic attack, not people without that history.

Comments

Be the first to comment.